Boston Scientific Slashes Earnings Guidance Post-Cyberattack

• Boston Scientific experienced a cyberattack that impacted its business operations.
• The company reported better-than-expected sales in Q3 2026.
• Despite higher sales, Boston Scientific's quarterly revenue guidance missed expectations.
• The cyberattack is one of the factors contributing to the lowered earnings guidance.
• Boston Scientific had previously warned about potential challenges affecting its performance.